Capital Analysts LLC’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-141
Closed -$6K – 1168
2023
Q2
$6K Buy
+141
New +$5.8K ﹤0.01% 865

Other funds holding BME

Capital Analysts LLC's BME Position: Q3 2023 in Review

Capital Analysts LLC sold out of BlackRock Health Sciences Trust (BME) in Q3 2023, closing a stake of 141 shares — an estimated $6K sold.

Capital Analysts LLC first reported a position in BME in Q2 2023 and held it in 1 quarter. The position peaked at $6K in Q2 2023. 72 funds tracked by Wall St. Rank hold BME as of Q3 2023.

  • Capital Analysts LLC reported no remaining BlackRock Health Sciences Trust position as of Q3 2023 after selling out during the quarter.
  • Capital Analysts LLC sold 141 BlackRock Health Sciences Trust shares in Q3 2023, an estimated $6K.
  • Capital Analysts LLC first reported a position in BlackRock Health Sciences Trust in Q2 2023 and held it in 1 quarter.
  • Capital Analysts LLC's BlackRock Health Sciences Trust position peaked at $6K in Q2 2023.
  • 72 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q3 2023.

Based on Capital Analysts LLC's 13F filing for Q3 2023, filed 13 Nov 2023.